Sweden’s investments have fostered energy that is green, affordable, and stable, supporting sustainable growth in sectors including battery cell production and hydrogen-based, fossil fuel-free steel production.

Life sciences represent one of the largest export categories and stand testament to the nation’s long-standing commitment to medical innovation and scientific excellence. In a unique ecosystem with world-class research institutions, collaborating closely with industry to drive breakthrough discoveries, we continue to shape the future of global healthcare and science through cutting-edge research and development.

  • Annual R&D investments of €5 billion in Life Sciences
  • 4,000 companies and high rate of university spinouts
  • Large exporter of pharmaceutical products (€13 billion annually)
  • Unique IP rights for academic research enable early-stage commercialization
  • Open research infrastructure with an extensive network of biobanks and health data registries
  • Extensive infrastructure for Advance Therapy Medicinal Products (ATMP)

How would you like to engage with Swedish life sciences? Contact us today and we'll help you get there.